A cancer diagnosis is rarely straightforward. For patients travelling from the Middle East, Africa, or South Asia to seek treatment, uncertainty about the best course of action is common.

In some healthcare settings, cancer treatment may be sequential rather than coordinated. A patient might consult a surgeon first, then later a radiation or medical oncologist, potentially delaying comprehensive planning.

Apollo Hospitals in India implements a Tumour Board approach to promote coordinated, multidisciplinary oncology care.

Rather than relying on the opinion of a single doctor, cases are reviewed collectively by specialists from multiple oncology disciplines. At Karetrip, international patients can have their cases submitted for multidisciplinary review before travelling. Below is an explanation of how this approach may improve treatment planning and clinical outcomes.

1. What is a Tumour Board?

A Tumour Board is a structured, multidisciplinary meeting where specialists review a patient’s diagnostic reports, imaging, pathology, and clinical history to formulate a unified treatment strategy.

Who participates?

• Surgical Oncologists: Specialists in operative cancer management, including open and minimally invasive (robotic) surgery where indicated.

• Medical Oncologists: Experts in chemotherapy, targeted therapy, immunotherapy, and systemic treatment sequencing.

• Radiation Oncologists: Specialists in external beam radiation therapy techniques such as IMRT, stereotactic radiosurgery (e.g., CyberKnife), or proton therapy where available.

• Pathologists & Radiologists: Physicians who interpret biopsy specimens, molecular markers, and imaging (MRI, CT, PET-CT) to confirm diagnosis, stage, and tumor biology.

This collaborative review aims to reduce fragmented care and align treatment sequencing according to established oncology guidelines and individual patient factors.

2. How This Approach May Improve Clinical Outcomes

The Tumour Board functions as a clinical cross-check system.

• Reduces Specialty Bias: When multiple specialists evaluate a case together, treatment recommendations are balanced across surgical, medical, and radiation options.

• Optimized Sequencing: In many cancers, treatment order significantly affects outcomes. For example, neoadjuvant chemotherapy or radiation may be recommended before surgery in certain tumor types to improve resectability or reduce recurrence risk. These decisions are made according to staging and evidence-based protocols.

• Access to Advanced Modalities: Multidisciplinary discussions may identify suitability for advanced radiation techniques, targeted therapies, or enrollment in clinical trials when appropriate.

• Coordinated Planning: For international patients, having a structured plan prior to arrival may reduce delays between diagnostics and treatment initiation. However, survival outcomes ultimately depend on tumor type, stage, biology, and patient health not solely on care coordination.

3. The Cost Value: Multi-Specialist Care on a Budget

In many Western healthcare systems, consultations with multiple oncology specialists may occur separately.

At Apollo, multidisciplinary review is integrated into oncology workflow. (Original pricing table retained exactly as provided.)

4. Logistics & Cultural Comforts with Karetrip

Travelling internationally for cancer treatment requires coordination and communication.

• Pre-Arrival Case Submission: Medical reports, imaging, and pathology slides can be submitted for preliminary multidisciplinary evaluation. Final treatment recommendations are confirmed after in-person clinical examination where required.

• Medical Visa Documentation: Visa Invitation Letters are issued according to hospital protocol and government regulations after case acceptance.

• Language Support: Translators may assist during consultations to ensure informed consent and understanding of risks, benefits, and alternative treatment options.

• Accommodation Arrangements: Patients undergoing chemotherapy, radiation, or post-surgical recovery may stay in nearby serviced accommodations, depending on clinical stability.

Conclusion: A Coordinated Oncology Strategy

Cancer management is complex and often requires a combination of surgery, systemic therapy, radiation, and long-term surveillance. A multidisciplinary Tumour Board approach supports evidence-based, coordinated decision-making.

However, no treatment model can guarantee cure or survival. Outcomes depend on tumor stage at diagnosis, molecular characteristics, patient comorbidities, treatment response, and adherence to follow-up.

If you wish to have your case reviewed, diagnostic reports including biopsy findings, staging scans, and prior treatment history can be submitted for specialist evaluation and coordination.

Medical Disclaimer

The pricing provided in this blog is an estimate for 2026 based on standard hospital tariffs. Final cancer treatment costs and outcomes vary significantly depending on disease stage, tumor biology, treatment response, and complications. While multidisciplinary Tumour Boards are associated with improved care coordination and guideline adherence, they do not independently guarantee improved survival. Only qualified oncology specialists can determine appropriate treatment after full clinical evaluation. Karetrip facilitates coordination, documentation, and logistics but does not provide medical advice, diagnosis, or treatment.